Cumberland Pharmaceuticals CPIX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $11.01M-27.1% | $11.44M-36.3% | $15.2M-13.0% | $16.09M-7.2% | $15.11M-18.5% | ||
| $14.26M+36.0% | $16.94M+44.8% | $10.43M-7.8% | $10.32M-11.2% | $10.49M-1.5% | ||
| $9.88M-0.6% | $9.25M-15.9% | $9.18M-22.4% | $9.53M-19.7% | $9.94M-23.0% | ||
| $10.06M-7.1% | $9.83M-17.9% | $9.75M-20.8% | $10.38M-18.2% | $10.83M-15.2% | ||
| $5.27M+75.1% | $5.65M+94.9% | $2.32M-40.2% | $2.26M-31.6% | $3.01M-29.0% | ||
| $2.07M-5.3% | $2.45M-12.2% | $1.38M-29.4% | $1.58M-32.1% | $2.18M-18.7% | ||
| $32.79M+2.9% | $37.06M+1.7% | $29.94M-15.0% | $31.21M-12.3% | $31.88M-12.0% | ||
| $237.38K-20.5% | $264.72K-4.6% | $293.38K-6.0% | $297.79K-11.7% | $298.74K-19.1% | ||
| 9.4%0.0% | 9.4%-617,692,291% | 9.4%0.0% | 9.4%0.0% | 9.4%0.0% | ||
| $914K0.0% | $914K0.0% | $914K0.0% | $914K0.0% | $914K0.0% | ||
| $12.79M-24.7% | $14.03M-22.0% | $15.01M-22.7% | $15.99M-21.9% | $16.99M-21.1% | ||
| $100K-50.0% | $2.97M+6.8% | $100K-50.0% | $200K0.0% | $200K0.0% | ||
| $3.84M— | $3.99M— | —— | —— | —— | ||
| $71M+1.5% | $76.82M+1.6% | $65.9M-14.1% | $67.91M-13.5% | $69.94M-14.2% | ||
| $16.54M+18.7% | $18.57M+33.4% | $13.83M+14.7% | $13.45M+7.5% | $13.93M+6.5% | ||
| $12.98M+15.7% | $12.64M+3.1% | $10.08M-20.3% | $10.14M-14.6% | $11.22M-13.6% | ||
| —— | $0-100% | —— | —— | —— | ||
| $485.16K+30.7% | $467.77K+31.2% | $401.45K+2.5% | $386.08K+2.5% | $371.09K+2.4% | ||
| $34.49M+35.1% | $36.74M+16.2% | $24.31M-21.8% | $23.97M-3.2% | $25.52M-3.4% | ||
| $4.34M-10.0% | $4.47M-9.5% | $4.6M-8.0% | $4.71M-7.6% | $4.83M-7.1% | ||
| $4.83M-7.1% | $4.94M-6.7% | $5M-7.3% | $5.1M-6.9% | $5.2M-6.5% | ||
| $5.62M-6.4% | $5.82M-7.6% | $5.95M-2.3% | $6.3M-3.6% | $6.01M-9.1% | ||
| $49.69M+19.5% | $52.28M-1.4% | $40.1M-23.3% | $40.23M-23.4% | $41.6M-23.4% | ||
| $51.73M+0.7% | $51.68M+10.4% | $51.51M+10.0% | $51.44M+9.8% | $51.37M+9.5% | ||
| -$30.09M-32.5% | -$26.8M-11.8% | -$25.39M-15.1% | -$23.45M-14.3% | -$22.71M-16.9% | ||
| -$333.51K-5.4% | -$336.1K-9.3% | -$319.15K-3.1% | -$310.87K+1.9% | -$316.4K-5.5% | ||
| $21.64M-24.5% | $24.88M+8.9% | $26.12M+5.4% | $27.99M+6.2% | $28.66M+4.2% | ||
| $71M+1.5% | $76.82M+1.6% | $65.9M-14.1% | $67.91M-13.5% | $69.94M-14.2% | ||
| $5.27M+75.1% | $5.65M+94.9% | $2.32M-40.2% | $2.26M-31.6% | $3.01M-29.0% | ||
| $10.06M-7.1% | $9.83M-17.9% | $9.75M-20.8% | $10.38M-18.2% | $10.83M-15.2% | ||
| $100K-50.0% | —— | $100K-50.0% | $200K0.0% | $200K0.0% | ||
| $2.93M+6.7% | $2.97M+6.8% | $2.99M+5.6% | $2.85M-4.8% | $2.74M-10.4% | ||
| $100K-50.0% | $8.34M+35.1% | $100K-50.0% | $200K0.0% | $200K0.0% | ||
| $44.1M0.0% | —— | $44.1M0.0% | $44.1M0.0% | $44.1M0.0% | ||
| $12.79M-24.7% | $14.03M-22.0% | $15.01M-22.7% | $15.99M-21.9% | $16.99M-21.1% | ||
| $3.84M— | $3.99M— | —— | —— | —— | ||
| $7.62M+6.1% | $8.34M+35.1% | $7.57M+21.9% | $7.13M+11.9% | $7.18M+10.1% | ||
| $2.93M+6.7% | $2.97M+6.8% | $2.99M+5.6% | $2.85M-4.8% | $2.74M-10.4% | ||
| $7.62M+6.1% | $8.34M+35.1% | $7.57M+21.9% | $7.13M+11.9% | $7.18M+10.1% | ||
| $2.93M+6.7% | $2.97M+6.8% | $2.99M+5.6% | $2.85M-4.8% | $2.74M-10.4% | ||
| $12.98M+15.7% | $12.64M+3.1% | $10.08M-20.3% | $10.14M-14.6% | $11.22M-13.6% | ||
| $684.56K+11.0% | —— | $173.98K-20.3% | $395.66K-8.9% | $616.61K-5.1% | ||
| $740.79K-20.7% | —— | $934.18K+2.7% | $934.18K+2.7% | $934.18K+2.7% | ||
| $667.05K+2.5% | —— | $650.77K-12.2% | $650.77K-12.2% | $650.77K-12.2% | ||
| $740.79K-20.7% | —— | $934.18K+2.7% | $934.18K+2.7% | $934.18K+2.7% | ||
| $650.77K-12.2% | —— | $740.79K-20.7% | $740.79K-20.7% | $740.79K-20.7% | ||
| $667.05K+2.5% | —— | $650.77K-12.2% | $650.77K-12.2% | $650.77K-12.2% | ||
| $934.18K+2.7% | —— | $909.91K+8.8% | $909.91K+8.8% | $909.91K+8.8% | ||
| $5.24M— | $5.24M-48.5% | $0-100% | $0-100% | $0-100% | ||
| $7.21M-10.5% | —— | $7.61M-10.4% | $7.83M-10.1% | $8.05M-9.7% | ||
| $2.38M-16.5% | —— | $2.61M-15.8% | $2.73M-15.4% | $2.85M-15.1% | ||
| $650.77K-12.2% | —— | $740.79K-20.7% | $740.79K-20.7% | $740.79K-20.7% | ||
| $667.05K+2.5% | —— | $650.77K-12.2% | $650.77K-12.2% | $650.77K-12.2% | ||
| $4.83M-7.1% | $4.94M-52.5% | $5M-7.3% | $5.1M-6.9% | $5.2M-6.5% | ||
| $0.00— | $0.00— | $0.00— | $0.00— | —— | ||
| 15M+0.1% | 15M+7.2% | 15M+6.8% | 15M+6.2% | 15M+5.7% | ||
| $2.1M-4.5% | —— | $2.2M-12.0% | $2.2M-15.4% | $2.2M-21.4% | ||
| $2.1M-4.5% | —— | $2.2M-12.0% | $2.2M-15.4% | $2.2M-21.4% | ||
| $0— | $0— | $0— | $0— | —— | ||
| $100M0.0% | $100M0.0% | $100M0.0% | $100M0.0% | $100M0.0% | ||
| $14.98M+0.1% | $14.96M+7.2% | $14.96M+6.8% | $14.96M+6.2% | $14.96M+5.7% | ||
| $14.98M+0.1% | $14.96M+7.2% | $14.96M+6.8% | $14.96M+6.2% | $14.96M+5.7% | ||
| $4.49M— | $5.07M— | —— | —— | —— | ||
| $7.21M-10.5% | —— | $7.61M-10.4% | $7.83M-10.1% | $8.05M-9.7% | ||
| $3.53M-15.9% | —— | $4.2M-13.4% | $4.2M-13.4% | $4.2M-13.4% | ||
| $2.38M-16.5% | —— | $2.61M-15.8% | $2.73M-15.4% | $2.85M-15.1% | ||
| —— | —— | —— | —— | —— | ||
| $5.24M0.0% | $5.24M-48.5% | $5.24M-48.1% | $5.24M-67.4% | $5.24M-67.4% | ||
| -$333.51K-5.4% | -$336.1K-9.3% | -$319.15K-3.1% | -$310.87K+1.9% | -$316.4K-5.5% | ||
| $0.09-0.2% | $0.09-0.2% | $0.09-0.1% | $0.09-0.2% | $0.09-0.1% | ||
| $44.1M0.0% | —— | $44.1M0.0% | $44.1M0.0% | $44.1M0.0% | ||
| $2.1M-4.5% | —— | $2.2M-12.0% | $2.2M-15.4% | $2.2M-21.4% | ||
| $684.56K+11.0% | —— | $173.98K-20.3% | $395.66K-8.9% | $616.61K-5.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cumberland Pharmaceuticals's total assets?
- Cumberland Pharmaceuticals (CPIX) holds $71.0M in total assets, up 1.5% year over year.
- How much debt does Cumberland Pharmaceuticals have?
- Cumberland Pharmaceuticals carries $4.8M in total debt against $21.6M of shareholders' equity, a debt-to-equity ratio of 0.22.
- How much cash does Cumberland Pharmaceuticals have?
- Cumberland Pharmaceuticals holds $11.0M in cash and equivalents.
- Can Cumberland Pharmaceuticals cover its short-term obligations?
- Its current ratio is 0.95 — current liabilities exceed current assets.
- Where does Cumberland Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
